Press Coverage

The True Costs of Pivotal Trials that Support FDA Approval

Article summarizes a study co-authored by ISMP Senior Scientist Tom Moore and published online in JAMA Internal Medicine that explores the median costs for pivotal clinical trials leading to FDA approval for novel drugs.

For the full text of the article, visit Medscape online


More News

To kick off the new year and celebrate its 25th anniversary, the Institute for Safe Medication Practices (ISMP) has released several new tools and capabilities on its website, .
Please Give $25 or more to Honor 25 Years of Advancing Medication Safety In 2019, the Institute for Safe Medication Practices (ISMP) is celebrating 25 years of leading the way in medication safety. ISMP is the only 501c (3) nonprofit organization devoted entirely to preventing medication errors, and
Newsletter Article Addresses Lessons from Tragic Error A tragic medication error involving a neuromuscular blocker inspired the Institute for Safe Medication Practices (ISMP) to share lessons learned from the fatal event as well as prevention strategies in a recent newsletter article so that other